Semaglutide – GLP-1 Receptor Agonist Research Peptide
Semaglutide is a synthetic GLP-1 receptor agonist used in
laboratory research to study
glucose regulation, energy homeostasis, and cellular signaling pathways.
Due to its strong binding affinity to the GLP-1 receptor, Semaglutide serves as an
important model compound in metabolic and endocrine research.
Our Semaglutide is produced in controlled laboratory environments and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%.
Each batch is supplied as a stable lyophilized powder, suitable for research
applications requiring high accuracy and reproducibility.
Key specifications
| Specification | Value / description |
|---|---|
| Product name | Semaglutide (GLP-1 analogue) |
| Molecular formula | C187H291N45O59 |
| Molecular weight | ≈ 4,113.6 Da |
| Purity | ≥ 99% (HPLC tested) |
| Form | Lyophilized powder |
| Storage conditions | Store refrigerated, protected from light and moisture |
| Use type | Exclusively for in-vitro research purposes |
| COA / test report | Available upon request |
Research relevance
- Key research model in GLP-1 receptor signaling studies.
- Supports in-vitro research into glucose metabolism and
hormonally regulated energy processes. - Widely studied in laboratories focusing on metabolic regulation and endocrine pathways.
- Relevant for research into energy balance and weight-regulation mechanisms.
